8-119853082-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024094.3(DSCC1):āc.316A>Gā(p.Lys106Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000049 in 1,613,854 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_024094.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSCC1 | NM_024094.3 | c.316A>G | p.Lys106Glu | missense_variant | 2/9 | ENST00000313655.5 | NP_076999.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSCC1 | ENST00000313655.5 | c.316A>G | p.Lys106Glu | missense_variant | 2/9 | 1 | NM_024094.3 | ENSP00000322180.4 | ||
DSCC1 | ENST00000521795.1 | n.379A>G | non_coding_transcript_exon_variant | 2/2 | 2 | |||||
ENSG00000286362 | ENST00000665858.1 | n.203-1593T>C | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152172Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000875 AC: 22AN: 251322Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135832
GnomAD4 exome AF: 0.0000520 AC: 76AN: 1461682Hom.: 0 Cov.: 30 AF XY: 0.0000798 AC XY: 58AN XY: 727144
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152172Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 24, 2024 | The c.316A>G (p.K106E) alteration is located in exon 2 (coding exon 2) of the DSCC1 gene. This alteration results from a A to G substitution at nucleotide position 316, causing the lysine (K) at amino acid position 106 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at